GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integral Diagnostics Ltd (OTCPK:ITGDF) » Definitions » Valuation Rank

Integral Diagnostics (Integral Diagnostics) Valuation Rank


View and export this data going back to 2021. Start your Free Trial

What is Integral Diagnostics Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Integral Diagnostics Valuation Rank Related Terms

Thank you for viewing the detailed overview of Integral Diagnostics's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Integral Diagnostics (Integral Diagnostics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integral Diagnostics Ltd (OTCPK:ITGDF) » Definitions » Valuation Rank
Comparable Companies
ASX:ACL ASX:MVF ASX:HLS ASX:MAP ASX:GSS ASX:IIQ ASX:RHY ASX:LDX ASX:CTE ASX:BDX TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
IDX:Australia
Address
45 William Street, Suite 9.02, Level 9, Melbourne, VIC, AUS, 3000
Website
http://www.integraldiagnostics.com.au
Integral Diagnostics is Australia's fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.